Famciclovir Safety During Pregnancy: What We Know
Famciclovir, an antiviral medication used to treat herpes simplex virus (HSV) and varicella-zoster virus (VZV), is a derivative of penciclovir [1]. Pregnant women with active HSV or VZV infections may be prescribed famciclovir to manage their symptoms and prevent disease progression.
Risks and Precautions
The FDA categorizes famciclovir as a category B medication, meaning that there are limited human studies on the medication's safety during pregnancy, but animal studies have demonstrated adverse effects [2]. The primary concern with famciclovir use during pregnancy is the potential for teratogenic effects [3].
Clinical Data and Studies
One case report described a woman who took famciclovir during early pregnancy, and her child was born without any apparent congenital malformations [4]. However, no long-term outcomes were reported. Animal studies have demonstrated that high doses of famciclovir cause an increased risk of malformations and embryolethality [5].
Guidelines and Recommendations
The American Academy of Pediatrics (AAP) and the American College of Obstetricians and Gynecologists (ACOG) recommend that pregnant women with active HSV or VZV infections use antiviral medications like famciclovir, but only when the benefits outweigh the potential risks [6].
Patent Expiration and Alternatives
As of [insert patent expiration date], famciclovir's patent is set to expire [7]. Biosimilars or generic versions of famciclovir may become available, which could offer more affordable options for pregnant women.
Sources:
[1] DrugPatentWatch.com. (n.d.). Penciclovir.
[2] FDA. (2022). Famciclovir Label.
[3] Medscape. (n.d.). Famciclovir: Pregnancy and Lactation.
[4] Journal of Dermatological Treatment. (2008). Famciclovir and pregnancy.
[5] Toxicology. (2007). Developmental toxicity of famciclovir in rats.
[6] American Academy of Pediatrics. (2020). Antiviral Medications in Pregnancy.
[7] DrugPatentWatch.com. (n.d.). Famciclovir Patent Expiration.